| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 26 | 2025 | 608 | 5.930 |
Why?
|
| Immunoprecipitation | 8 | 2022 | 203 | 1.730 |
Why?
|
| RNA | 12 | 2024 | 600 | 1.710 |
Why?
|
| Binding Sites | 14 | 2022 | 1366 | 1.300 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 240 | 1.250 |
Why?
|
| Transcriptome | 7 | 2024 | 1121 | 1.050 |
Why?
|
| Gene Library | 2 | 2017 | 225 | 1.010 |
Why?
|
| RNA, Ribosomal | 3 | 2025 | 62 | 0.970 |
Why?
|
| RNA, Small Nucleolar | 1 | 2025 | 15 | 0.940 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 1905 | 0.930 |
Why?
|
| Sequence Analysis, RNA | 6 | 2019 | 427 | 0.830 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 75 | 0.780 |
Why?
|
| Computational Biology | 6 | 2019 | 886 | 0.780 |
Why?
|
| Cross-Linking Reagents | 3 | 2017 | 61 | 0.770 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2016 | 96 | 0.710 |
Why?
|
| Chromatin | 5 | 2020 | 606 | 0.690 |
Why?
|
| RNA Splicing | 8 | 2024 | 250 | 0.680 |
Why?
|
| Gene Regulatory Networks | 3 | 2013 | 396 | 0.660 |
Why?
|
| Alternative Splicing | 8 | 2023 | 373 | 0.640 |
Why?
|
| Protein Binding | 12 | 2024 | 1831 | 0.620 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2022 | 954 | 0.570 |
Why?
|
| Reverse Transcription | 1 | 2017 | 5 | 0.570 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 2653 | 0.530 |
Why?
|
| DNA | 3 | 2024 | 1665 | 0.530 |
Why?
|
| CRISPR-Cas Systems | 3 | 2021 | 286 | 0.510 |
Why?
|
| Staining and Labeling | 1 | 2016 | 187 | 0.510 |
Why?
|
| K562 Cells | 5 | 2020 | 100 | 0.500 |
Why?
|
| RNA, Messenger | 9 | 2024 | 2895 | 0.490 |
Why?
|
| Introns | 4 | 2024 | 313 | 0.470 |
Why?
|
| Genome, Helminth | 2 | 2011 | 12 | 0.460 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1334 | 0.450 |
Why?
|
| Spliceosomes | 3 | 2025 | 57 | 0.430 |
Why?
|
| Base Sequence | 8 | 2020 | 3168 | 0.420 |
Why?
|
| Hep G2 Cells | 5 | 2023 | 93 | 0.420 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 584 | 0.400 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 66 | 0.400 |
Why?
|
| Databases, Genetic | 3 | 2020 | 501 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 567 | 0.380 |
Why?
|
| Adenosine Deaminase | 3 | 2021 | 89 | 0.370 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 161 | 0.370 |
Why?
|
| RNA, Small Nuclear | 2 | 2025 | 50 | 0.370 |
Why?
|
| Longevity | 1 | 2013 | 158 | 0.370 |
Why?
|
| RNA Editing | 3 | 2021 | 36 | 0.350 |
Why?
|
| Transcription Factors | 4 | 2013 | 2701 | 0.310 |
Why?
|
| Animals | 22 | 2025 | 36266 | 0.300 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 395 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1046 | 0.260 |
Why?
|
| Humans | 37 | 2025 | 133540 | 0.260 |
Why?
|
| Cell Line | 4 | 2020 | 2833 | 0.260 |
Why?
|
| Protein Isoforms | 2 | 2018 | 426 | 0.230 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2024 | 23 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group M | 1 | 2024 | 5 | 0.230 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2024 | 37 | 0.220 |
Why?
|
| RNA Polymerase II | 1 | 2024 | 102 | 0.220 |
Why?
|
| RNA Splice Sites | 3 | 2024 | 98 | 0.220 |
Why?
|
| HEK293 Cells | 4 | 2024 | 805 | 0.220 |
Why?
|
| 3' Untranslated Regions | 4 | 2019 | 182 | 0.220 |
Why?
|
| Aging | 4 | 2016 | 1303 | 0.210 |
Why?
|
| Nucleic Acid Conformation | 3 | 2024 | 197 | 0.210 |
Why?
|
| Mice | 13 | 2025 | 18808 | 0.210 |
Why?
|
| Organ Specificity | 3 | 2013 | 444 | 0.210 |
Why?
|
| Nucleotide Motifs | 4 | 2018 | 48 | 0.200 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2023 | 52 | 0.200 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2020 | 71 | 0.200 |
Why?
|
| Exons | 5 | 2024 | 833 | 0.200 |
Why?
|
| Optical Imaging | 1 | 2023 | 74 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2021 | 1 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2020 | 170 | 0.190 |
Why?
|
| Genomics | 3 | 2020 | 1668 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2021 | 114 | 0.170 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 12 | 0.170 |
Why?
|
| Intracellular Space | 1 | 2020 | 51 | 0.170 |
Why?
|
| Blast Crisis | 1 | 2020 | 16 | 0.170 |
Why?
|
| Genome | 2 | 2020 | 524 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2022 | 947 | 0.170 |
Why?
|
| Retroelements | 1 | 2020 | 41 | 0.170 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 142 | 0.170 |
Why?
|
| Antibodies | 2 | 2023 | 382 | 0.160 |
Why?
|
| Substrate Specificity | 1 | 2020 | 310 | 0.160 |
Why?
|
| Ribosome Subunits, Small | 1 | 2019 | 3 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 789 | 0.160 |
Why?
|
| RNA Precursors | 2 | 2019 | 65 | 0.160 |
Why?
|
| Genetic Variation | 2 | 2019 | 1611 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2019 | 72 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2020 | 372 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 177 | 0.150 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 369 | 0.150 |
Why?
|
| Ribosomes | 1 | 2019 | 139 | 0.150 |
Why?
|
| RNA Stability | 2 | 2016 | 84 | 0.150 |
Why?
|
| Metformin | 1 | 2020 | 162 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 168 | 0.150 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2018 | 19 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2022 | 867 | 0.140 |
Why?
|
| Glioma | 1 | 2023 | 534 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 62 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2023 | 1245 | 0.140 |
Why?
|
| Conserved Sequence | 3 | 2010 | 298 | 0.140 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 103 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 425 | 0.140 |
Why?
|
| Alu Elements | 3 | 2024 | 66 | 0.140 |
Why?
|
| Exonucleases | 1 | 2017 | 25 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 887 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2017 | 79 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 1753 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 11 | 0.130 |
Why?
|
| Cluster Analysis | 3 | 2013 | 436 | 0.130 |
Why?
|
| Alleles | 2 | 2019 | 1704 | 0.130 |
Why?
|
| Endonucleases | 1 | 2016 | 54 | 0.130 |
Why?
|
| Protein Domains | 1 | 2017 | 251 | 0.130 |
Why?
|
| Homologous Recombination | 1 | 2016 | 100 | 0.130 |
Why?
|
| Software | 2 | 2018 | 735 | 0.130 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 7 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2016 | 6 | 0.130 |
Why?
|
| RNA-Binding Motifs | 1 | 2016 | 3 | 0.130 |
Why?
|
| RNA Interference | 2 | 2020 | 536 | 0.130 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 13 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 82 | 0.130 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 58 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2016 | 157 | 0.120 |
Why?
|
| Datasets as Topic | 1 | 2016 | 104 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2016 | 77 | 0.120 |
Why?
|
| Mutation | 4 | 2017 | 6260 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 78 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 912 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 387 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 215 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2018 | 365 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2016 | 920 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2020 | 861 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 369 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 190 | 0.110 |
Why?
|
| DNA Repair | 1 | 2017 | 628 | 0.110 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 29 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1160 | 0.110 |
Why?
|
| Genome, Human | 2 | 2020 | 1348 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 871 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 231 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 2111 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 9 | 0.100 |
Why?
|
| Registries | 1 | 2020 | 1559 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2015 | 482 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 82 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 1632 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 861 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 247 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2013 | 69 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1128 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3719 | 0.090 |
Why?
|
| Systems Biology | 1 | 2011 | 63 | 0.090 |
Why?
|
| Algorithms | 2 | 2016 | 1728 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1929 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 382 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 664 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 165 | 0.080 |
Why?
|
| RNA Splicing Factors | 2 | 2023 | 55 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 563 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2020 | 4879 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 813 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 710 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2020 | 301 | 0.070 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 16 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 776 | 0.070 |
Why?
|
| Gene Expression | 3 | 2016 | 1612 | 0.070 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2006 | 6 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 3211 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 456 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 246 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2024 | 64 | 0.060 |
Why?
|
| DNA, Superhelical | 1 | 2024 | 21 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2024 | 69 | 0.060 |
Why?
|
| Phenotype | 1 | 2013 | 4523 | 0.050 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2023 | 11 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 145 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 92 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2024 | 228 | 0.050 |
Why?
|
| Histones | 2 | 2020 | 568 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2022 | 50 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 3007 | 0.050 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 24 | 0.050 |
Why?
|
| Cytosol | 1 | 2021 | 168 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2023 | 827 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 231 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 2020 | 14 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2020 | 52 | 0.040 |
Why?
|
| DNA Replication Timing | 1 | 2020 | 11 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 153 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 44 | 0.040 |
Why?
|
| Transposases | 1 | 2020 | 45 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1598 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 127 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2020 | 37 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 172 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 224 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 643 | 0.040 |
Why?
|
| Male | 3 | 2020 | 65774 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 611 | 0.040 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2019 | 3 | 0.040 |
Why?
|
| Inosine | 1 | 2019 | 12 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 392 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 201 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 66 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2019 | 69 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 118 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2018 | 126 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 134 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 319 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2017 | 8 | 0.030 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2016 | 3 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 612 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2016 | 55 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 1085 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 327 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 478 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1698 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 694 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 124 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2016 | 57 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 149 | 0.030 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 23 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 432 | 0.030 |
Why?
|
| Female | 2 | 2020 | 71524 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 212 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 700 | 0.030 |
Why?
|
| Integrins | 1 | 2016 | 103 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 182 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 262 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 363 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 827 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4786 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2524 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 452 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 231 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2805 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 417 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 687 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 710 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 435 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 284 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 453 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1603 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 895 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 537 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1065 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 709 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 843 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 3063 | 0.020 |
Why?
|
| Intestines | 1 | 2016 | 613 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 22 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1124 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 837 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 549 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 120 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1405 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1407 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2935 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4742 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3631 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 2034 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3471 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 789 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 82 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 256 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1531 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3161 | 0.010 |
Why?
|